Shanghai Haohai Biological Technology Co., Ltd.
SSE:688366.SS
51.96 (CNY) • At close June 9, 2025
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 2,679.667 | 2,634.91 | 2,103.438 | 1,750.116 | 1,324.427 | 1,595.498 | 1,545.824 | 1,344.856 | 851.157 | 663.917 | 515.94 | 401.088 | 303.065 |
| Kosten van de omzet
| 810.879 | 781.401 | 656.515 | 490.37 | 334.004 | 363.999 | 334.286 | 287.467 | 141.551 | 105.073 | 65.883 | 54.836 | 50.313 |
| Brutowinst
| 1,868.788 | 1,853.509 | 1,446.923 | 1,259.746 | 990.423 | 1,231.499 | 1,211.538 | 1,057.389 | 709.606 | 558.844 | 450.057 | 346.252 | 252.752 |
| Brutowinstmarge
| 0.697 | 0.703 | 0.688 | 0.72 | 0.748 | 0.772 | 0.784 | 0.786 | 0.834 | 0.842 | 0.872 | 0.863 | 0.834 |
| Onderzoek- en ontwikkelingskosten
| 238.929 | 220.098 | 182.192 | 167.597 | 126.474 | 116.076 | 95.37 | 76.332 | 47.255 | 35.254 | 26.46 | 23.521 | 17.575 |
| Algemene en administratieve kosten
| 446.975 | 422.346 | 405.304 | 286.093 | 216.759 | 268.985 | 242.41 | 194.754 | 90.19 | 58.878 | 48.96 | 34.221 | 36.272 |
| Verkoop- en marketingkosten
| 780.85 | 814.508 | 679.532 | 612.341 | 555.727 | 544.128 | 495.075 | 414.083 | 287.757 | 242.1 | 187.191 | 143.315 | 72.537 |
| Verkoop-, algemene en administratieve kosten
| 1,227.825 | 1,236.854 | 1,084.836 | 898.434 | 772.486 | 813.113 | 737.485 | 608.837 | 377.947 | 300.978 | 236.151 | 177.536 | 108.809 |
| Overige kosten
| -44.16 | -41.82 | -40.276 | -33.88 | -33.882 | 107.742 | 0.341 | -16.307 | -5.44 | 0.637 | -1.551 | 0 | 0 |
| Bedrijfskosten
| 1,422.594 | 1,415.132 | 1,226.752 | 1,032.151 | 865.078 | 929.189 | 768.415 | 641.872 | 399.559 | 306.17 | 236.947 | 183.605 | 121.76 |
| Bedrijfsresultaat
| 446.194 | 438.377 | 258.66 | 384.43 | 260.562 | 437.964 | 443.123 | 415.517 | 372.904 | 321.356 | 218.21 | 142.79 | 125.832 |
| Bedrijfsresultaat ratio
| 0.167 | 0.166 | 0.123 | 0.22 | 0.197 | 0.274 | 0.287 | 0.309 | 0.438 | 0.484 | 0.423 | 0.356 | 0.415 |
| Totaal overige inkomsten en kosten netto
| 19.951 | 69.883 | -26.439 | -1.781 | -3.536 | -3.615 | 82.062 | 46.104 | 81.911 | 98.035 | -2.594 | 21.272 | 7.6 |
| Inkomen voor belasting
| 466.145 | 508.26 | 235.726 | 382.649 | 257.026 | 434.349 | 525.185 | 461.621 | 365.885 | 320.647 | 215.616 | 166.467 | 133.432 |
| Inkomen voor belasting ratio
| 0.174 | 0.193 | 0.112 | 0.219 | 0.194 | 0.272 | 0.34 | 0.343 | 0.43 | 0.483 | 0.418 | 0.415 | 0.44 |
| Belastingkosten
| 89.902 | 95.991 | 45.395 | 35.366 | 30.686 | 57.972 | 70.106 | 61.609 | 55.258 | 47.341 | 32.034 | 24.946 | 19.49 |
| Nettowinst
| 420.447 | 416.121 | 180.47 | 352.234 | 230.072 | 370.779 | 414.54 | 372.415 | 305.052 | 273.474 | 183.582 | 141.521 | 113.942 |
| Nettowinstmarge
| 0.157 | 0.158 | 0.086 | 0.201 | 0.174 | 0.232 | 0.268 | 0.277 | 0.358 | 0.412 | 0.356 | 0.353 | 0.376 |
| WPA (Winst Per Aandeel)
| 1.8 | 1.74 | 1.04 | 2 | 1.3 | 2.08 | 2.59 | 2.33 | 1.91 | 1.86 | 1.15 | 1.18 | 0.95 |
| Verwaterde WPA
| 1.8 | 1.74 | 1.04 | 2 | 1.3 | 2.08 | 2.59 | 2.33 | 1.91 | 1.86 | 1.15 | 1.18 | 0.95 |
| EBITDA
| 689.432 | 712.954 | 444.041 | 548.256 | 394.802 | 554.314 | 600.474 | 533.084 | 400.876 | 286.721 | 235.951 | 154.712 | 147.042 |
| EBITDA ratio
| 0.257 | 0.271 | 0.211 | 0.313 | 0.298 | 0.347 | 0.388 | 0.396 | 0.471 | 0.432 | 0.457 | 0.386 | 0.485 |